Article ; Online: Controlled release of dexamethasone from fibrin sealant for intratympanic administration in inner ear therapy.
2023 Volume 19, Issue 1, Page(s) 55–58
Abstract: The aim of the present work was to show the sustainability of fibrin sealant in releasing dexamethasone and adjust the protocol for clinical application of the novel method in the treatment of Meniere's disease (MD) and sudden sensorineural hearing loss ( ...
Abstract | The aim of the present work was to show the sustainability of fibrin sealant in releasing dexamethasone and adjust the protocol for clinical application of the novel method in the treatment of Meniere's disease (MD) and sudden sensorineural hearing loss (SSHL). Gelation occurred shortly after mixing dexamethasone-containing fibrinogen with thrombin. Dexamethasone was constantly released for at least 16 d at a stable level after 7 d in protocol 1 (low-dose), while it was robustly released within 4 d and slowed afterward until 10 d in protocol 2 (high-dose). There were significant differences among the time points in Protocol 2 (p < 0.01, ANOVA), and the exponential model with the formula y = 15.299 * e |
---|---|
Language | English |
Publishing date | 2023-11-16 |
Publishing country | China |
Document type | Journal Article |
ZDB-ID | 2621477-5 |
ISSN | 2524-1753 ; 1672-2930 |
ISSN (online) | 2524-1753 |
ISSN | 1672-2930 |
DOI | 10.1016/j.joto.2023.11.002 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.